Recent News


    • Cartoon of a rat as it searchers for food with postural and orofacial movements

      Neurobiologist David Kleinfeld to Lead $15 million NIH study

      Multimillion-dollar study will reverse-engineer the facial movements mammals use to survive, resulting in a comprehensive 3D brain circuitry atlas

      Face and head movements noticed in mammals as they breathe and rummage for food is the subject of a $15-million study supported by the National Institutes of Health. Scientists from the University of California San Diego, Ben Gurion University, Duke University and Laval University, with support from colleagues at Cold Spring Harbor Laboratories and the HHMI Janelia Research Center, will conduct the research to explore how mammals sniff, nod, and move their faces and mouths—backwards.

    • View of Geisel

      Report Ranks UC San Diego Biology-Biochemistry as Ninth Best in World

      Neuroscience, Microbiology and Molecular Biology-Genetics also rank as top programs

      The University of California San Diego has been named the nation’s fifth best public university, according to U.S. News and World’s Report’s Best Global Universities. The publication released a new list measuring factors such as research; global and regional reputation; international collaboration; as well as the number of highly-cited papers and doctorates awarded. Overall, UC San Diego was ranked the 17th best university in the world.

    • Homa Rahnamoun

      Graduate Students Honored with 2018 Founding Faculty Awards

      Homa Rahnamoun and Ipshita Zutshi recognized for research excellence

      Homa Rahnamoun and Ipshita Zutshi, Division of Biological Sciences graduate students, have been honored with 2018 Biology Founding Faculty Awards for Graduate Excellence.

    • Microscopic screenshot of pancreatic cells re-sensitized to chemotherapeutic treatment

      Biologists Discover Source for Boosting Tumor Cell Drug Sensitivity

      Gene that inhibits HIV identified as a potential candidate for cancer treatments

      DNA-damaging agents, or “DDAs,” make up the most widely used group of cancer drugs. Yet their therapeutic success has been curtailed by drug resistance—either present in cancer cells from the disease onset or arising during treatment.

    • Headshot of Rachel Dutton

      Rachel Dutton and David Traver Recognized with NIH’s High-Risk, High-Reward Awards

      Three researchers at the University of California San Diego have been selected to receive 2018 NIH Director’s New Innovator Awards. In addition, David Traver from the UC San Diego School of Medicine, has received an NIH Director’s Transformative award.

    • Taking out the (Life-threatening) Garbage: Bacteria Eject Trash to Survive

      ‘Minicell’ pods, used in drug delivery, discard damaged proteins to prolong life

      Scientists have known for decades that certain bacteria produce small spherical versions of themselves. Although they lack basic materials to reproduce or function like normal cells, recent interest in such “minicells” has spiked due to their proficiency as nano-sized delivery tools for drugs and vaccines to targeted cells and tissues.

    • Physicists Train Robotic Gliders to Soar like Birds

      The novel study applies reinforcement learning to set a course toward artificial intelligence

    • Ribbon cutting ceremony

      Nikon Imaging Center Opens at UC San Diego

      The Nikon Imaging Center, a collaborative microscopy center that provides local researchers with access to the latest imaging technologies, opened September 13, 2018 at the University of California San Diego.

    • Sergey Kryazhimskiy

      Sergey Kryazhimskiy Awarded Hellman Fellowship

      Division of Biological Sciences Assistant Professor Sergey Kryazhimskiy has been awarded a Hellman Fellowship for 2018-2019. He is one of 11 UC San Diego faculty members to receive the award, which is designed to provide financial support to promising early career faculty who show a capacity for distinction in their research and creative activities.

    • RNAs interacting with BRD4

      Byproducts of ‘Junk DNA’ Implicated in Cancer Spread

      Emerging class of RNAs keep tumor-promoting genes turned on

      Only an estimated two percent of the human genome encodes for functional proteins that carry out normal biological processes. The remaining approximately 98 percent—the “junk DNA”—has for many years been considered a useless artifact.

    To read more about Division of Biological Sciences happenings, see the News Archives.